AMLX(AMLX)
AMLX
ANALYST COVERAGE10 analysts
BUY
▲ +84.4%upside to target
L $21.00
Med $24.50consensus
H $28.00PRICE
Prev Close
13.88
Open
13.54
Day Range13.17 – 13.90
13.17
13.90
52W Range4.64 – 18.61
4.64
18.61
62% of range
VOLUME & SIZE
Avg Volume
1.1M
FUNDAMENTALS
P/E Ratio
-9.0x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
34
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 115 days
Sep 10
Key MetricsTTM
Market Cap$1.10B
Revenue TTM$0.00
Net Income TTM-$150.11M
Free Cash Flow-$120.53M
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity-55.7%
Return on Assets-51.1%
Debt / Equity0.02
Current Ratio17.85
EPS TTM$-1.36
AMLX News
About
No description available.
Camille L. BedrosianChief Medical Officer
Jamie TimmonsHead of Global Medical Strategy & Communications
Machelle ManuelVice President & Head of Global Medical Affairs
Dan MonahanChief Commercial Officer
Joshua CohenCo-Founder, Co-CEO & Director
Justin KleeCo-CEO & Director
Tom HolmesChief Technical Operations Officer
Gina MazzarielloChief Legal Officer & General Counsel
Linda A. ArsenaultChief Human Resources Officer
Lindsey AllenHead of Investor Relations & Communications
Tammy SarnelliGlobal Head of Regulatory Affairs
James FratesChief Financial Officer